New Breed Of Biotech Investors Show Their Hand With $10 Billion Investment In London Startup LabGenius | Tampa Florida Management Consulting | Scoop.it
From www.ops.coach - October 23, 2019 8:21 AM
In leading the $10 billion investment in LabGenius, two U.S. venture capital funds Lux Capital and Obvious Ventures reveal a biotech investing strategy not seen from the old guard of life science financing.